4//SEC Filing
REGENERON PHARMACEUTICALS INC 4
Accession 0001237899-16-000089
$REGNCIK 0000872589operating
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 4:15 PM ET
Size
12.7 KB
Accession
0001237899-16-000089
Insider Transaction Report
Form 4
Powchik Peter
SVP Clinical Development
Transactions
- Gift
Common Stock
2016-05-16−2,459→ 0 total(indirect: by GRAT) - Gift
Common Stock
2016-05-16−2,459→ 2,459 total(indirect: by GRAT) - Award
Non-Qualified Stock Option (right to buy)
2016-12-16+5,000→ 5,000 totalExercise: $381.92Exp: 2026-12-16→ Common Stock (5,000 underlying) - Gift
Common Stock
2016-05-16+2,459→ 2,459 total(indirect: By Trust) - Gift
Common Stock
2016-05-16+2,459→ 2,459 total(indirect: By Trust)
Holdings
- 1,674(indirect: By 401(k))
Common Stock
- 25,714
Common Stock
Footnotes (3)
- [F1]By a trust for the benefit of the reporting person's son of which the reporting person's spouse is trustee.
- [F2]By a trust for the benefit of the reporting person's daughter of which the reporting person's spouse is trustee.
- [F3]The stock option award vests in full one year after the date of grant.
Documents
Issuer
REGENERON PHARMACEUTICALS INC
CIK 0000872589
Entity typeoperating
IncorporatedNY
Related Parties
1- filerCIK 0000872589
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 4:15 PM ET
- Size
- 12.7 KB